Freedman Joseph S.

13D and 13G Filings

13D/G filings
13D on 1 security
CIK
0002043590
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 1 security · may seek to influence control
Eupraxia Pharmaceuticals Inc. 13D/A
EPRX · 29842P105
9.0% 3/16/2026
Event 3/13/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.